Cleared Traditional

BD6000 THE OPTIMA & BD5000 BIRTHING BED (K914544) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1993
Decision
776d
Days
Class 2
Risk

K914544 is an FDA 510(k) clearance for the BD6000 THE OPTIMA & BD5000 BIRTHING BED. Classified as Table, Obstetric (and Accessories) (product code KNC), Class II - Special Controls.

Submitted by Lic Care, Inc. (Arlington Heights, US). The FDA issued a Cleared decision on November 24, 1993 after a review of 776 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4900 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Lic Care, Inc. devices

Submission Details

510(k) Number K914544 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 10, 1991
Decision Date November 24, 1993
Days to Decision 776 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
616d slower than avg
Panel avg: 160d · This submission: 776d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KNC Table, Obstetric (and Accessories)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.4900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.